Osaic Holdings
INKT icon

Osaic Holdings’s MiNK Therapeutics INKT Stock Holding History

Osaic Holdings’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37K Buy
117
+116
+11,600% +$1.35K ﹤0.01% 7396
2026
Q1 		$10 Sell
1
-116
-99% -$1.29K ﹤0.01% 7742
2025
Q4 		$1.3K Sell
117
-7
-6% -$90 ﹤0.01% 7204
2025
Q3 		$1.7K Buy
124
+4
+3% +$64 ﹤0.01% 7186
2025
Q2 		$883 Sell
120
-118
-50% -$887 ﹤0.01% 7197
2025
Q1 		$2.05K Buy
238
+106
+80% +$944 ﹤0.01% 6586
2024
Q4 		$918 Sell
132
-11
-8% -$75 ﹤0.01% 6869
2024
Q3 		$1.07K Hold
143
– – ﹤0.01% 6822
2024
Q2 		$1.36K Buy
143
+51
+55% +$496 ﹤0.01% 6733
2024
Q1 		$832 Buy
92
+63
+217% +$584 ﹤0.01% 6722
2023
Q4 		$309 Sell
29
-11
-28% -$115 ﹤0.01% 6963
2023
Q3 		$440 Buy
40
+5
+14% +$81 ﹤0.01% 7016
2023
Q2 		$733 Buy
+35
New +$701 ﹤0.01% 6962

Other funds holding INKT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Osaic Holdings's INKT Position: Q2 2026 in Review

Osaic Holdings increased its MiNK Therapeutics (INKT) stake by 11,600% in Q2 2026, buying an estimated $1.35K and bringing the position to 117 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #7396.

Osaic Holdings first reported a position in INKT in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.05K in Q1 2025. 27 funds tracked by Wall St. Rank hold INKT as of Q2 2026.

  • Osaic Holdings held 117 shares of MiNK Therapeutics worth $1.37K as of Q2 2026.
  • Osaic Holdings bought 116 MiNK Therapeutics shares in Q2 2026, an estimated $1.35K.
  • MiNK Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7396 holding.
  • Osaic Holdings first reported a position in MiNK Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Osaic Holdings's MiNK Therapeutics position peaked at $2.05K in Q1 2025.
  • 27 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.